Taprenepag
CAS: 752187-80-7
Rif. 3D-CFB18780
| 5mg | Prezzo su richiesta | |
| 10mg | Prezzo su richiesta | |
| 25mg | Prezzo su richiesta | |
| 50mg | Prezzo su richiesta | |
| 100mg | Prezzo su richiesta |
Informazioni sul prodotto
Taprenepag is a prodrug that is hydrolyzed to its active form, the camphor derivative, in the body. Camphor derivatives are a class of compounds that are used as drugs and have been shown to have anticancer activity. Taprenepag has been shown to inhibit the growth of cervical cancer cells by binding to response element-binding protein (RBP) and inhibiting cell proliferation. It also inhibits angiogenic factors such as vascular endothelial growth factor (VEGF) and erythropoietin (EPO), which are involved in tumor growth. The compound also inhibits PI3K/Akt/mTOR signaling pathway, which may contribute to its anti-cancer activity. Taprenepag has been shown to be effective in models of bowel disease, such as inflammatory bowel disease and ulcerative colitis. In addition, this drug has been studied for use in skin cancer treatment with benzalkonium chloride.
Proprietà chimiche
Richiesta tecnica su: 3D-CFB18780 Taprenepag
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
